Abstract:Hydrogen sulfide (H2 S), independently of any specific transporters, has a number of biological effects on the cardiovascular system. However, until now, the detailed mechanism of H2 S was not clear. Recently, a novel post-translational modification induced by H2 S, named S-sulfhydration, has been proposed. S-sulfhydration is the chemical modification of specific cysteine residues of target proteins by H2 S. There are several methods for detecting S-sulfhydration, such as the modified biotin switch assay, maleimide assay with fluorescent thiol modifying regents, tag-switch method and mass spectrometry. H2 S induces S-sulfhydration on enzymes or receptors (such as p66Shc, phospholamban, protein tyrosine phosphatase 1B, mitogen-activated extracellular signal-regulated kinase 1 and ATP synthase subunit α), transcription factors (such as specific protein-1, kelch-like ECH-associating protein 1, NF-κB and interferon regulatory factor-1), and ion channels (such as voltage-activated Ca2+ channels, transient receptor potential channels and ATP-sensitive K+ channels) in the cardiovascular system. Although significant progress has been achieved in delineating the role of protein S-sulfhydration by H2 S in the cardiovascular system, more proteins with detailed cysteine sites of S-sulfhydration as well as physiological function need to be investigated in further studies. This review mainly summarizes the role and possible mechanism of S-sulfhydration in the cardiovascular system. The S-sulfhydrated proteins may be potential novel targets for therapeutic intervention and drug design in the cardiovascular system, which may accelerate the development and application of H2 S-related drugs in the future.This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.

Hydrogen Sulfide as a Potential Alternative for the Treatment of Myocardial Fibrosis

Hydrogen Sulfide as a Potential Therapeutic Target in Fibrosis

Inhibition of NADPH Oxidase 4-Related Signaling by Sodium Hydrosulfide Attenuates Myocardial Fibrotic Response.

Hydrogen Sulfide Donor GYY4137 Protects Against Myocardial Fibrosis

Hydrogen Sulfide Inhibits Myocardial Injury Induced by Homocysteine in Rats

The Cardioprotective Effects of Hydrogen Sulfide in Heart Diseases: from Molecular Mechanisms to Therapeutic Potential

Sodium Hydrosulfide Prevents Myocardial Dysfunction Through Modulation of Extracellular Matrix Accumulation and Vascular Density

Hydrogen Sulfide (H2S)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases

Hydrogen Sulfide Ameliorates Angiotensin II-Induced Atrial Fibrosis Progression to Atrial Fibrillation Through Inhibition of the Warburg Effect and Endoplasmic Reticulum Stress

Protein S‐sulfhydration by Hydrogen Sulfide in Cardiovascular System

Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice

Exogenous Hydrogen Sulfide Ameliorates Diabetic Myocardial Fibrosis by Inhibiting Cell Aging Through SIRT6/AMPK Autophagy

Role of Hydrogen Sulfide in Myocardial Ischemia–Reperfusion Injury

Hydrogen Sulfide Regulating Myocardial Structure and Function by Targeting Cardiomyocyte Autophagy

Hydrogen Sulfide Attenuates Cardiac Dysfunction in a Rat Model of Heart Failure: a Mechanism Through Cardiac Mitochondrial Protection

Hydrogen Sulfide and Its Possible Roles in Myocardial Ischemia in Experimental Rats

Hydrogen Sulfide Mitigates Myocardial Infarction Via Promotion of Mitochondrial Biogenesis-Dependent M2 Polarization of Macrophages.

Roles of Hydrogen Sulfide (H2S) as a Potential Therapeutic Agent in Cardiovascular Diseases: A Narrative Review

P42Hydrogen Sulfide is a Promising Therapeutic Strategy for Atherosclerosis

The Role of Hydrogen Sulfide on Cardiovascular Homeostasis: an Overview with Update on Immunomodulation

Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis.